# FDA Inspection 1313374 - Cipla Limited - April 17, 2026

Source: https://www.keypedia.com/records/fda_inspections/cipla-limited/489043bc-019c-4418-931e-6518183cfd6b
Source feed: FDA_Inspections

> FDA Inspection 1313374 for Cipla Limited on April 17, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1313374
- Company Name: Cipla Limited
- Inspection Date: 2026-04-17
- Project Area: Generic Drug Evaluation
- Office Name: Office of Inspections and Investigations

## Related Documents

- [FDA Inspection 1313374 - 2026-04-17](https://www.keypedia.com/records/fda_inspections/cipla-limited/47decda4-77f8-4163-ab2d-e0cd8c50e259)
- [FDA Inspection 1240813 - 2024-06-21](https://www.keypedia.com/records/fda_inspections/cipla-limited/8bbdb860-88af-47ff-ac3a-04cb8bedbcad)
- [FDA Inspection 1178952 - 2022-08-26](https://www.keypedia.com/records/fda_inspections/cipla-limited/dc52b0e2-2947-4e2d-9bdf-1a9dc7fb515e)
- [FDA Inspection 1103305 - 2019-09-27](https://www.keypedia.com/records/fda_inspections/cipla-limited/8e4dda74-73d5-4f2e-853a-19cf3d2511d5)
- [FDA Inspection 1103305 - 2019-09-27](https://www.keypedia.com/records/fda_inspections/cipla-limited/3d4ad184-ec01-4b07-8d4c-c5a5edc56a1a)

Company: https://www.keypedia.com/companies/cipla-limited/6b5864ed-07a2-4861-b424-021018d4f7e9

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8